IL33846A - Derivatives of 1-thiachromone and 4-thionchromone,their preparation and pharmaceutical compositions containing them - Google Patents
Derivatives of 1-thiachromone and 4-thionchromone,their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL33846A IL33846A IL33846A IL3384670A IL33846A IL 33846 A IL33846 A IL 33846A IL 33846 A IL33846 A IL 33846A IL 3384670 A IL3384670 A IL 3384670A IL 33846 A IL33846 A IL 33846A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- formula
- carbon
- pharmaceutically acceptable
- group containing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims 3
- DHSYDTXGFJPXKA-UHFFFAOYSA-N thiochromen-4-one Chemical class C1=CC=C2C(=O)C=CSC2=C1 DHSYDTXGFJPXKA-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 22
- 239000000203 mixture Substances 0.000 claims abstract 8
- 125000000217 alkyl group Chemical group 0.000 claims abstract 6
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract 6
- 125000003545 alkoxy group Chemical group 0.000 claims abstract 5
- 150000001408 amides Chemical class 0.000 claims abstract 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract 5
- 125000004008 6 membered carbocyclic group Chemical group 0.000 claims abstract 3
- 238000006243 chemical reaction Methods 0.000 claims abstract 3
- 150000002148 esters Chemical class 0.000 claims abstract 3
- 150000003839 salts Chemical class 0.000 claims abstract 3
- 125000003302 alkenyloxy group Chemical group 0.000 claims abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 8
- 229910052799 carbon Inorganic materials 0.000 claims 8
- 238000000034 method Methods 0.000 claims 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 4
- 239000001301 oxygen Substances 0.000 claims 4
- 229910052760 oxygen Inorganic materials 0.000 claims 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 2
- 239000005864 Sulphur Substances 0.000 claims 2
- 150000001263 acyl chlorides Chemical group 0.000 claims 2
- -1 alkali metal cation Chemical class 0.000 claims 2
- 125000005907 alkyl ester group Chemical group 0.000 claims 2
- 239000000460 chlorine Substances 0.000 claims 2
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- 125000004122 cyclic group Chemical group 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 241000237519 Bivalvia Species 0.000 claims 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 239000003513 alkali Substances 0.000 claims 1
- 229910052783 alkali metal Inorganic materials 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 235000020639 clam Nutrition 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 159000000000 sodium salts Chemical class 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 abstract 1
- 125000001054 5 membered carbocyclic group Chemical group 0.000 abstract 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 abstract 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- HUYWAWARQUIQLE-UHFFFAOYSA-N Isoetharine Chemical compound CC(C)NC(CC)C(O)C1=CC=C(O)C(O)=C1 HUYWAWARQUIQLE-UHFFFAOYSA-N 0.000 abstract 1
- 208000024780 Urticaria Diseases 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000005083 alkoxyalkoxy group Chemical group 0.000 abstract 1
- 230000001088 anti-asthma Effects 0.000 abstract 1
- 239000000924 antiasthmatic agent Substances 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 229940124630 bronchodilator Drugs 0.000 abstract 1
- 150000001733 carboxylic acid esters Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000005113 hydroxyalkoxy group Chemical group 0.000 abstract 1
- 229960001268 isoetarine Drugs 0.000 abstract 1
- 229960001317 isoprenaline Drugs 0.000 abstract 1
- LMOINURANNBYCM-UHFFFAOYSA-N metaproterenol Chemical compound CC(C)NCC(O)C1=CC(O)=CC(O)=C1 LMOINURANNBYCM-UHFFFAOYSA-N 0.000 abstract 1
- 229960002657 orciprenaline Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
1291864 Anti-asthmatic medicines FISONS PHARMACEUTICALS Ltd 2 Feb 1970 [12 Feb 1969] 7467/69 Heading ASB [Also in Division C2] Therapeutic compositions for the treatment 'extrinsic' and 'intrinsic' asthma, and other conditions, such as hay fever, urticaria and autoimmune diseases, in which antigen-antibody reactions are responsible for disease, by administration orally, parenterally or topically, or by inhalation, comprise compounds of formula: or their pharmaceutically acceptable derivatives (e.g. salts, esters or amides), wherein one of V and W is O, and the other is S; and P, Q, R, T are each H, halogen, C 1-10 alkyl, OH, alkoxy, hydroxyalkoxy, alkoxyalkoxy, AcO, CO 2 H, NH 2 , alkyl-NH, (alkyl) 2 N, alkenyl, aralkyl (up to C 10 ), Ph, NO 2 , carboxylic ester, alkenyloxy or acyl, or an adjacent pair of P, Q, R, T together with the adjacent carbon atoms in the benzene ring form a fused 5- or 6-membered carbocyclic or heterocyclic ring. For administration by inhalation, the compositions may include a bronchodilator such as isoprenaline, adrenaline, orciprenaline, isoetharine or their pharmaceutically acceptable derivatives.
[GB1291864A]
Claims (1)
1. 42 CLAMS Processes for the preparation of compounds of the formula in which and which may he the same or each represent an alkyl group containing from 1 to 10 carbon a alkoxy or carboxy the above groups containing up to 10 carbon a carbalkoxy or or an adjacent pair of R and together with the adjacent carbon atoms in the benzene ring may form a fused or 6 cyclic membered V and which are each represent oxygen or provided not all of and are when and are all hydrogen is not a chlorine when I is a methoxy and are 7 is oxygen and W is p is not a methyl when V is sulphur and is one of R and is alkoxy or an adjacent pair of R and T together with the adjacent carbon atoms of the benzene a 6 membered carbocyclic and pharmaceutically acceptable alkyl esters or unsubstituted amides which comprise producing a of formula in which T and the provisos are as defined by cyclising a compound of formula p in which T and the provisos are as defined and represents or an alkali producing a of formula in which provisos are defined by treating a corresponding compound of formula 44 or of P in which III and IV and the provisos are a defined and represents an alkali metal cation or an alkyl with phosphorous pentasulp and where desired converting the compound of I produced a acceptable derivative A process according to part of Claim wherein the cyclisation is carried out in the presence of a dehydrating A process according to part of Claim wherein the cyclisation is effected by converting the groups in the compound of formula II to acyl chloride groups and subjecting the resulting acyl chloride to an internal Friedel Crafts A process according to part of Claim wherein the reaction is carried out at elevated temperature in a solvent which is inert under the reaction A process as claimed in Claim 1 and substantially as hereinbefore described in any one of Examples 1 to A process for the production of a pharmaceutically acceptable salt of a compound of formula as defined in Claim which comprises converting the compound of formula a different salt an ester or an amide thereof to the desired 45 Compounds of formula I in Claim whenever produced by a process according to any one of Claims 1 to Compounds of formula as defined in Claim A compound of formula in which and the provisos are as defined in Claim A compound of formula in which and the provisos are as defined in Claim A compound according to any of Claims 8 to wherein R and which may be the same or each represent bromine or an alkyl group containing from 1 to 6 carbon a hydroxy an group containing from 1 to 10 carbon a carboxy a phenyl a nitro a carbalkoxy group containing from 1 to 6 carbon an group containing from 1 to 6 carbon or R and 46 together with adjacent carbon atoms in the benzene ring form the chains compound according to any of Claims 8 to in which R and which may be the same or each represent chlorine or a nitro or an or group containing from 1 to 6 carboy or an adjacent pair of and form an alkylene or A compound according to any of Claims 8 to wherein P represents lic lic A compound according to any one of Claims 8 to in the form of a pharmaceutically acceptable ester or amide 47 A compound according to any one of Claims 7 to in the form of the sodium salt lie ethyl Ethyl carbox A pharmaceutical composition comprising a compound o formula 48 which R and which may be the same or each represent an alkyl group containing from 1 to 10 carbon a alkoxy or carboxy the above groups containing up to 10 carbon a carbalkoxy or alkenyloxy or an adjacent pair of R and together with the adjacent carbon atoms in the benzene ring may form a fused or 6 cyclic V and which are each Kpresent oxygen or except V is sulphur and W is oxygen one of R and T is alkoxy or an adjacent pair of and T together with the adjacent Carbon atoms of the a 6 membered carbocyclic rin or a pharmaceutically acceptable alkyl ester or unsubstituted amide as active in combinati with a pharmaceutically acceptable diluent or A composition according to Claim wherein the compound of formula I c is a compound according to any one of Claims 7 to A composition according to either of Claims 38 and incorporating a b ronchodilator A composition according to any of Claims 38 to in a form suitable for administration of a dose of from to 50 mgs of active A pharmaceutical composition according to Claim substantially as hereinbefore 49 A composition according to any of Claims 40 and the active ingredient is one of the compounds of 27 to A composition according to any of Claims 40 and wherein the active ingredient is one of the compounds of Claims 30 to composition according to any of Claims 40 and wherein the active ingredient is the compound of Claim insufficientOCRQuality
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7467/69A GB1291864A (en) | 1969-02-12 | 1969-02-12 | Mono thiachromone-2-carboxylic acids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL33846A0 IL33846A0 (en) | 1970-04-20 |
| IL33846A true IL33846A (en) | 1976-04-30 |
Family
ID=9833661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL33846A IL33846A (en) | 1969-02-12 | 1970-02-05 | Derivatives of 1-thiachromone and 4-thionchromone,their preparation and pharmaceutical compositions containing them |
Country Status (9)
| Country | Link |
|---|---|
| JP (2) | JPS4835266B1 (en) |
| CH (5) | CH557346A (en) |
| DE (1) | DE2006196A1 (en) |
| DK (1) | DK128420B (en) |
| FR (1) | FR2034538B1 (en) |
| GB (1) | GB1291864A (en) |
| IL (1) | IL33846A (en) |
| NL (1) | NL7001922A (en) |
| SE (1) | SE367634B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1362782A (en) * | 1970-08-26 | 1974-08-07 | Fisons Ltd | Tetrazole derivatives |
| BE769146A (en) * | 1970-07-01 | 1971-11-03 | Takeda Chemical Industries Ltd | CHROMON-CARBOXYLIC ACID DERIVATIVES |
| GB1391615A (en) * | 1971-09-30 | 1975-04-23 | Fisons Ltd | 4-oxo-4h-1-benzopyran and 4-oxo-4h-1-thia benzopyran derivatives |
| JPS50112055U (en) * | 1974-02-22 | 1975-09-12 | ||
| CA1065329A (en) * | 1974-11-30 | 1979-10-30 | Richard Hazard | Chromone derivatives |
| US4159273A (en) * | 1974-11-30 | 1979-06-26 | Fisons Limited | Tricyclic mono-chromone-2-carboxylic acids |
| EP0079637B1 (en) * | 1981-11-12 | 1987-01-28 | FISONS plc | Anti-srs-a carboxylic acid derivatives, processes for their production, and pharmaceutical formulation containing them |
| US4888356A (en) * | 1983-08-08 | 1989-12-19 | G. D. Searle And Company | Use of substituted dihydrobenzopyrans for allergy and inflammation |
| US4778903A (en) * | 1983-12-12 | 1988-10-18 | G. D. Searle & Co. | Substituted dihydrobenzopyrans |
| US4665203A (en) * | 1983-08-08 | 1987-05-12 | G. D. Searle & Co. | Substituted dihydrobenzopyrans useful as leukotriene D4 inhibitors |
| US4565882A (en) * | 1984-01-06 | 1986-01-21 | G. D. Searle & Co. | Substituted dihydrobenzopyran-2-carboxylates |
| US4644071A (en) * | 1984-07-11 | 1987-02-17 | G. D. Searle & Co. | Aralkoxy and aryloxyalkoxy kojic acid derivatives |
-
1969
- 1969-02-12 GB GB7467/69A patent/GB1291864A/en not_active Expired
-
1970
- 1970-02-05 IL IL33846A patent/IL33846A/en unknown
- 1970-02-10 FR FR7004568A patent/FR2034538B1/fr not_active Expired
- 1970-02-11 CH CH178672A patent/CH557346A/en not_active IP Right Cessation
- 1970-02-11 DE DE19702006196 patent/DE2006196A1/en active Pending
- 1970-02-11 CH CH178572A patent/CH560712A5/xx not_active IP Right Cessation
- 1970-02-11 CH CH196970A patent/CH551437A/en not_active IP Right Cessation
- 1970-02-11 DK DK66870AA patent/DK128420B/en unknown
- 1970-02-11 CH CH178372A patent/CH551438A/en not_active IP Right Cessation
- 1970-02-11 CH CH178472A patent/CH557811A/en not_active IP Right Cessation
- 1970-02-11 NL NL7001922A patent/NL7001922A/xx unknown
- 1970-02-11 SE SE01744/70A patent/SE367634B/xx unknown
-
1972
- 1972-08-25 JP JP47084683A patent/JPS4835266B1/ja active Pending
- 1972-08-25 JP JP47084684A patent/JPS4835267B1/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NL7001922A (en) | 1970-08-14 |
| JPS4835266B1 (en) | 1973-10-26 |
| FR2034538A1 (en) | 1970-12-11 |
| IL33846A0 (en) | 1970-04-20 |
| JPS4835267B1 (en) | 1973-10-26 |
| FR2034538B1 (en) | 1974-08-30 |
| CH551437A (en) | 1974-07-15 |
| SE367634B (en) | 1974-06-04 |
| CH557346A (en) | 1974-12-31 |
| CH557811A (en) | 1975-01-15 |
| CH560712A5 (en) | 1975-04-15 |
| CH551438A (en) | 1974-07-15 |
| DK128420B (en) | 1974-04-29 |
| DE2006196A1 (en) | 1970-11-05 |
| GB1291864A (en) | 1972-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4440785A (en) | Methods of using 2-aminobiphenylacetic acids, esters, and metal salts thereof to treat inflammation | |
| JPS6354321A (en) | Blood sugar lowering agent | |
| IL33846A (en) | Derivatives of 1-thiachromone and 4-thionchromone,their preparation and pharmaceutical compositions containing them | |
| US3853923A (en) | 2-substituted-(2-hydroxy-3-lower alkaminopropoxy)-benzofurans | |
| US3506667A (en) | Furo quinoline carboxylates | |
| SE7705637L (en) | PROCEDURE FOR THE PREPARATION OF DIBENSOXEPIN DERIVATIVES WITH THERAPEUTIC EFFECT | |
| US4389408A (en) | Novel ampicillin esters and production thereof | |
| HUT46895A (en) | Process for production of new 5-lipoxigenase bicyclic compounds with inhibiation effect | |
| GB1355147A (en) | Oxoprostanoic acid derivatives | |
| US3740437A (en) | Naphthyloxyacetic acids and pharmaceutical compositions and methods thereof | |
| US3306909A (en) | 3-carbamoyl-1,5-diphenyl-2,4-pyrrolidinediones | |
| GB1353304A (en) | Process for production of diketopiperazine dihydroxamates and intermediate therefor | |
| IE36716B1 (en) | Substituted cyclic urea derivatives and pharmaceutical compositions containing them | |
| JPS5653656A (en) | Quinoline derivative and its preparation | |
| CH640526A5 (en) | METHOD FOR PRODUCING NEW BENZOPYRANE DERIVATIVES. | |
| EP0102175A1 (en) | 5-Oxo-5H-(1)benzopyrano(2,3-b)pyridine derivatives, their production and use | |
| US3647802A (en) | 2-amino-4-aryl-3 4-dihydroquinolines | |
| US3714206A (en) | Benzo-2,3,1-diazaborines | |
| EP0000488A1 (en) | 3-Oxaloamino-4-oxo-4H-1-benzopyrane compounds, process for their preparation and their pharmaceutical use | |
| US4018818A (en) | Hydroxyl-substituted 2-chloro-α-(tert-butylaminomethyl)-benzylalcohols | |
| US3060206A (en) | 2, 4-disulfamyl-5-alkoxy-aniline | |
| GB1384843A (en) | Benzofuran derivatives their preparation and compositions containing them | |
| IE33870B1 (en) | Benzobenzofuranooxepine compounds and process for preparing the same | |
| US3169127A (en) | Derivatives of penicillin amides | |
| US2989530A (en) | Nu-(5-nitro-2-furoyl)-morpholine |